HIV and GI Tract Complications A Comprehensive Clinical Guide
This text provides a concise yet comprehensive review of GI tract complications of HIV infection. Beginning with an overview on the pathophysiology of HIV and its direct effect on the GI tract, the book outlines opportunistic infections, noninfectious eti
- PDF / 2,789,819 Bytes
- 206 Pages / 439.43 x 683.15 pts Page_size
- 39 Downloads / 237 Views
Lisa M. Chirch Jurate Ivanaviciene Editors
HIV and GI Tract Complications A Comprehensive Clinical Guide
Clinical Gastroenterology
Series Editor: George Y. Wu Division of Gastroenterology-Hepatology University of Connecticut School of Medicine Farmington, CT, USA
More information about this series at http://www.springer.com/series/7672
Lisa M. Chirch • Jurate Ivanaviciene Editors
HIV and GI Tract Complications A Comprehensive Clinical Guide
Editors Lisa M. Chirch Division of Infectious Diseases University of Connecticut School of Medicine Farmington, CT USA
Jurate Ivanaviciene Division of Infectious Diseases St. Vincent’s Medical Center Bridgeport, CT USA
ISSN 2197-7399 ISSN 2197-7704 (electronic) Clinical Gastroenterology ISBN 978-3-030-13376-4 ISBN 978-3-030-13377-1 (eBook) https://doi.org/10.1007/978-3-030-13377-1 © Springer Nature Switzerland AG 2019 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Humana Press imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Preface
The last three decades have witnessed dramatic strides in our ability to successfully treat and manage infection with the human immunodeficiency virus (HIV). The ongoing development and availability of more effective and better-tolerated antiretroviral (ARV) medications have contributed to this, resulting in virologic suppression in a majority of patients taking ARVs. The rollout of certain ARVs for pre-exposure prophylaxis or “PrEP” represents an example of successful innovation to reduce the number of new infections. However, we continue to see new increasing numbers of new infections, particularly in certain patient populations, such as young men who have sex with men (MSM) and those of Hispanic or African descent. Coinfection with other viruses, such as hep
Data Loading...
